Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application.

To access publisher's full text version of this article click on the hyperlink at the bottom of the page The polysaccharide chitosan and the water soluble chitosan derivative N,N,N-trimethyl chitosan (TMC) have been widely investigated as permeation enhancers of mucosal surfaces with numerous p...

Full description

Bibliographic Details
Published in:Journal of Controlled Release
Main Authors: Benediktsdóttir, Berglind Eva, Baldursson, Ólafur, Másson, Már
Other Authors: Univ Iceland, Sch Hlth Sci, Fac Pharmaceut Sci, IS-107 Reykjavik, Iceland, Landspitali, Dept Pulm Med, IS-101 Reykjavik, Iceland
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier Science BV 2014
Subjects:
Lyf
Online Access:http://hdl.handle.net/2336/325618
id ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/325618
record_format openpolar
spelling ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/325618 2023-05-15T16:48:21+02:00 Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application. Benediktsdóttir, Berglind Eva Baldursson, Ólafur Másson, Már Univ Iceland, Sch Hlth Sci, Fac Pharmaceut Sci, IS-107 Reykjavik, Iceland, Landspitali, Dept Pulm Med, IS-101 Reykjavik, Iceland 2014 http://hdl.handle.net/2336/325618 en eng Elsevier Science BV http://dx.doi.org/10.1016/j.jconrel.2013.10.022 J Control Release. 2014, 173:18-31 1873-4995 24511609 http://hdl.handle.net/2336/325618 Journal of controlled release : official journal of the Controlled Release Society Archived with thanks to Journal of controlled release : official journal of the Controlled Release Society National Consortium - Landsaðgangur Öndunarfæri Lyf Animals Chitosan/chemical synthesis Drug Carriers/chemical synthesis Humans Intestinal Mucosa/metabolism* Respiratory Mucosa/metabolism* Chitosan/chemistry Chitosan/metabolism* Drug Carriers/chemistry Drug Carriers/metabolism* Article 2014 ftlandspitaliuni https://doi.org/10.1016/j.jconrel.2013.10.022 2022-05-29T08:21:59Z To access publisher's full text version of this article click on the hyperlink at the bottom of the page The polysaccharide chitosan and the water soluble chitosan derivative N,N,N-trimethyl chitosan (TMC) have been widely investigated as permeation enhancers of mucosal surfaces with numerous papers published over the last two decades. Although both chitosan and TMC increase permeation of markers through mucosal membranes, such as the intestinal and airway epithelium as well as in in vivo models, these investigations have not led to their use in marketed drug formulations. In this review, the reported extent of the permeation enhancement and cell viability after chitosan or TMC treatment in intestinal and airway models is critically evaluated and concluded that the apparent discrepancies can be explained by differences in polymer structure, experimental conditions and in vitro models. Additionally, aspects regarding the synthesis of TMC and its structural characterization are described, focusing on new synthetic strategies implemented to reduce O-methylation. Finally recommendations are provided on how studies can be conducted to improve understanding of the structure–activity relationship and elucidate possible mechanism of action. Eimskip Fund of University of Iceland, University of Iceland Research Fund, Landspitali University Hospital Science Fund, Bergthóra and Thorsteins Scheving Thorsteinssonar Fund Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive Journal of Controlled Release 173 18 31
institution Open Polar
collection Hirsla - Landspítali University Hospital research archive
op_collection_id ftlandspitaliuni
language English
topic Öndunarfæri
Lyf
Animals
Chitosan/chemical synthesis
Drug Carriers/chemical synthesis
Humans
Intestinal Mucosa/metabolism*
Respiratory Mucosa/metabolism*
Chitosan/chemistry
Chitosan/metabolism*
Drug Carriers/chemistry
Drug Carriers/metabolism*
spellingShingle Öndunarfæri
Lyf
Animals
Chitosan/chemical synthesis
Drug Carriers/chemical synthesis
Humans
Intestinal Mucosa/metabolism*
Respiratory Mucosa/metabolism*
Chitosan/chemistry
Chitosan/metabolism*
Drug Carriers/chemistry
Drug Carriers/metabolism*
Benediktsdóttir, Berglind Eva
Baldursson, Ólafur
Másson, Már
Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application.
topic_facet Öndunarfæri
Lyf
Animals
Chitosan/chemical synthesis
Drug Carriers/chemical synthesis
Humans
Intestinal Mucosa/metabolism*
Respiratory Mucosa/metabolism*
Chitosan/chemistry
Chitosan/metabolism*
Drug Carriers/chemistry
Drug Carriers/metabolism*
description To access publisher's full text version of this article click on the hyperlink at the bottom of the page The polysaccharide chitosan and the water soluble chitosan derivative N,N,N-trimethyl chitosan (TMC) have been widely investigated as permeation enhancers of mucosal surfaces with numerous papers published over the last two decades. Although both chitosan and TMC increase permeation of markers through mucosal membranes, such as the intestinal and airway epithelium as well as in in vivo models, these investigations have not led to their use in marketed drug formulations. In this review, the reported extent of the permeation enhancement and cell viability after chitosan or TMC treatment in intestinal and airway models is critically evaluated and concluded that the apparent discrepancies can be explained by differences in polymer structure, experimental conditions and in vitro models. Additionally, aspects regarding the synthesis of TMC and its structural characterization are described, focusing on new synthetic strategies implemented to reduce O-methylation. Finally recommendations are provided on how studies can be conducted to improve understanding of the structure–activity relationship and elucidate possible mechanism of action. Eimskip Fund of University of Iceland, University of Iceland Research Fund, Landspitali University Hospital Science Fund, Bergthóra and Thorsteins Scheving Thorsteinssonar Fund
author2 Univ Iceland, Sch Hlth Sci, Fac Pharmaceut Sci, IS-107 Reykjavik, Iceland, Landspitali, Dept Pulm Med, IS-101 Reykjavik, Iceland
format Article in Journal/Newspaper
author Benediktsdóttir, Berglind Eva
Baldursson, Ólafur
Másson, Már
author_facet Benediktsdóttir, Berglind Eva
Baldursson, Ólafur
Másson, Már
author_sort Benediktsdóttir, Berglind Eva
title Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application.
title_short Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application.
title_full Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application.
title_fullStr Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application.
title_full_unstemmed Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application.
title_sort challenges in evaluation of chitosan and trimethylated chitosan (tmc) as mucosal permeation enhancers: from synthesis to in vitro application.
publisher Elsevier Science BV
publishDate 2014
url http://hdl.handle.net/2336/325618
genre Iceland
genre_facet Iceland
op_relation http://dx.doi.org/10.1016/j.jconrel.2013.10.022
J Control Release. 2014, 173:18-31
1873-4995
24511609
http://hdl.handle.net/2336/325618
Journal of controlled release : official journal of the Controlled Release Society
op_rights Archived with thanks to Journal of controlled release : official journal of the Controlled Release Society
National Consortium - Landsaðgangur
op_doi https://doi.org/10.1016/j.jconrel.2013.10.022
container_title Journal of Controlled Release
container_volume 173
container_start_page 18
op_container_end_page 31
_version_ 1766038458153828352